Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 11, 2021
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Haruki Uojima, Nobuhiro Hattori, et al.
Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.
Clinical and Experimental Gastroenterology|October 16, 2020
Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter AnalysisKatsuaki Ogushi, Makoto Chuma, Haruki Uojima, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2026
Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesisXian-Yang Qin, Yali Xu, Hricha Mishra, et al.
Lancet (London, England)|October 23, 2023
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trialShukui Qin, Minshan Chen, Ann-Lii Cheng, et al.
Journal of Medical Ultrasound|September 3, 2020
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidJae Young Lee, Yasunori Minami, Byung Ihn Choi, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib TreatmentMakoto Chuma, Hideki Yokoo, Atsushi Hiraoka, et al.
Ultrasonography (Seoul, Korea)|May 26, 2020
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidJae Young Lee, Yasunori Minami, Byung Ihn Choi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2020
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Haruki Uojima, Atsushi Hiraoka, et al.
Liver Cancer|August 20, 2025
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational StudyYoon Jun Kim, Philippe Merle, Richard S Finn, et al.
Pageof 20